Atrasentan shows clinically meaningful effects on kidney function in IgA nephropathy patients, including those receiving SGLT2 inhibitors.

Authors say a personalized approach to hormone therapy use with regular reassessment of risks and benefits is needed.

Odds increased for 30-day readmission, intensive care unit level of care, in-hospital mortality, and prolonged hospital LOS.

Risk for diagnosed ADRD significantly lower for those with speed training plus booster sessions, but not for those without booster sessions.

(HealthDay News) — Higher consumption of ultraprocessed food (UPF) after cancer diagnosis is associated with increased rates of all-cause and cancer mortality, regardless of diet quality, according to ...

Use of an app-based digital therapeutic significantly reduces urinary incontinence episodes when added to usual care in women with stress, urge, or mixed urinary incontinence, according to results of ...

Investigators reported results from the first randomized controlled trial of office-based laser photocoagulation to standard TURBT for low-grade Ta bladder tumors.

The FDA has given the green light to beetroot red and has also sanctioned the use of spirulina extract. (HealthDay News) — ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

In a phase 3 trial, oral ferric citrate effectively raised hemoglobin and improved iron parameters in Taiwanese patients with iron deficiency anemia over 16 weeks. Ferric citrate significantly ...

A study supports targeted conversion of kidney transplant recipients with a history of cutaneous squamous cell carcinoma ...